Kehoe Law Firm, P.C. is investigating whether the directors of Covetrus, Inc. (“Covetrus”) (NASDAQ: CVET) breached their fiduciary duties to its shareholders in approving a buyout with funds affiliated with Clayton, Dubilier & Rice (“CD&R”) and TPG Capital (“TPG”) for inadequate consideration.
INVESTORS OF COVETRUS STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR COVETRUS STOCK HOLDINGS.
On May 25, 2022, Covetrus announced it had reached an agreement to be bought out by funds affiliated with CD&R and TPG for $21.00 per share, in an all-cash transaction valued at approximately $4 billion.
The investigation concerns whether Covetrus’s board of directors failed to maximize the value of Covetrus for the benefit of Covetrus’s shareholders in connection with its announced buyout by funds affiliated with CD&R and TPG, in breach of their fiduciary duties to Covetrus’s shareholders, and whether Covetrus’s shareholders suffered damages as a result.